FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $9,572,000 | +2581.2% | 254,090 | +1111.9% | 0.01% | – |
Q4 2020 | $357,000 | +275.8% | 20,966 | -14.5% | 0.00% | – |
Q3 2019 | $95,000 | -51.3% | 24,513 | -24.3% | 0.00% | – |
Q2 2019 | $195,000 | -44.1% | 32,362 | +24.7% | 0.00% | – |
Q1 2019 | $349,000 | +35.3% | 25,956 | -6.6% | 0.00% | – |
Q4 2018 | $258,000 | -19.6% | 27,787 | +20.2% | 0.00% | – |
Q3 2018 | $321,000 | -51.2% | 23,121 | -44.5% | 0.00% | -100.0% |
Q2 2018 | $658,000 | -17.5% | 41,629 | -10.4% | 0.00% | 0.0% |
Q1 2018 | $798,000 | +1.5% | 46,439 | +29.3% | 0.00% | 0.0% |
Q4 2017 | $786,000 | -78.0% | 35,913 | -58.8% | 0.00% | -66.7% |
Q3 2017 | $3,566,000 | +32.8% | 87,127 | -2.3% | 0.00% | 0.0% |
Q2 2017 | $2,685,000 | -31.1% | 89,171 | -17.3% | 0.00% | -25.0% |
Q1 2017 | $3,898,000 | +2.3% | 107,793 | +41.7% | 0.00% | 0.0% |
Q4 2016 | $3,811,000 | -5.3% | 76,053 | -0.8% | 0.00% | 0.0% |
Q3 2016 | $4,026,000 | +51.3% | 76,696 | +19.1% | 0.00% | +33.3% |
Q2 2016 | $2,661,000 | +9.1% | 64,371 | +7.3% | 0.00% | 0.0% |
Q1 2016 | $2,440,000 | +557.7% | 60,019 | +570.5% | 0.00% | – |
Q4 2015 | $371,000 | +78.4% | 8,952 | -33.8% | 0.00% | – |
Q3 2015 | $208,000 | -85.7% | 13,524 | -76.9% | 0.00% | -100.0% |
Q2 2015 | $1,456,000 | +56.2% | 58,597 | +43.7% | 0.00% | 0.0% |
Q1 2015 | $932,000 | +81.3% | 40,790 | +114.3% | 0.00% | – |
Q4 2014 | $514,000 | – | 19,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|